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Abstract 
In the presence of albumin Merocyanine 540 (MC540) exhibits a very limited binding to the outer surface of the membrane of normal 
erythrocytes, whereas pronounced binding is observed to leukemia cells. To find out whether this difference is due to differences in the 
composition or structural organization of the cell membrane we analyzed effects of a number of covalent and non-covalent perturbations 
of the red cell membrane on the binding and fluorescence characteristics of membrane-bound MC540. It is shown that exposure of the 
cells to cationic hlorpromazine, neuraminidase or photodynamic treatment with mlPcS 4 as sensitizer caused a limited increase (30-50%) 
of MC540 binding, together with a red shift of the fluorescence emission maximum and an increase of the relative fluorescence quantum 
yield of membrane-bound MC540. Other forms of perturbation of the membrane structure, like hyperthermia (48 ° C) and treatments hat 
produce a decrease of phospholipid asymmetry in addition to accelerated flip-flop, did not result in increased MC540 binding, but did 
cause a red shift of the fluorescence emission maximum and an increase of the relative fluorescence quantum yield. These changes in 
fluorescence properties indicate a penetration of the dye into more hydrophobic regions in the membrane. MC540, bound to Brown 
Norway myelocytic leukemia cells, exhibited a red shift of the fluorescence emission maximum and an increased relative fluorescence 
quantum yield as compared to MC540 bound to untreated erythrocytes. These changes were of the same order of magnitude as in 
photodynamically treated red blood cells. Dye binding per surface area, however, was about 3-times higher with these leukemia cells than 
with photodynamically treated red blood cells. This demonstrates that certain perturbations of the erythrocyte membrane evoked a MC540 
binding that became qualitatively comparable to the dye binding to leukemia cells, although dye binding per surface area was still 
significantly lower. 
Keywords: Merocyanine 540; Erythrocyte membrane; Leukemia cell 
I. Introduction 
Merocyanine 540 is a heterocyclic chromophore with a 
localized negative charge, that does not readily penetrate 
intact cells. Binding to intact cells is therefore initially 
Abbreviations: A1PcS4, aluminum chlorotetrasulfophthalocyanine; 
BNML cells, Brown Norway myelocytic leukemia cells; BSA, bovine 
serum albumin; DIDS, 4,4'-diisothiocyanostilbene-2,2'-disulfonate; 
MC540, Merocyanine 540; PBS, phosphate-buffered saline; PEG, 
poly(ethylene glycol); t-BuOOH, t-butylhydroperoxide; TMA-DPH, 1- 
(4-trimethylammoniumphenyl)-6-phenyl-l,3,5-hexatriene. 
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limited to the outer leaflet of the lipid bilayer of the 
plasma membrane [1]. Many recent studies address the 
possible use of MC540 as photosensitizer for bone marrow 
purging in the treatment of leukemia [1-4]. This is based 
on the observation that MC540 effectively sensitizes the 
photodynamic killing of leukemia cells, whereas normal 
bone marrow and blood cells are much less affected. It 
appeared that the different sensitivities of leukemia and 
normal cells can, at least partly, be ascribed to the much 
higher binding of the sensitizer to leukemia cells (' high-af- 
finity binding') compared to normal cells ( ' low-aff inity 
binding') [5,6]. That means that the therapeutic efficiency 
of MC540-sensitized photodynamic bone marrow purging 
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might be increased by manipulating the binding of MC540 
to normal and/or malignant cells. In this context it is 
important o clarify the molecular and structural back- 
ground of low-affinity binding of MC540 to normal cells, 
versus high-affinity binding to leukemia cells. 
Considering the MC540 binding to the outer membrane 
leaflet, the difference between high- and low-affinity bind- 
ing must reflect differences in composition and/or struc- 
tural organization of the membrane. Based on experiments 
with liposomes it was shown that MC540 binds prefer- 
entially to cholesterol-free phospholipid omains in mem- 
branes and to bilayers with relatively loose fatty acid 
packing [7-10]. In accordance it has been suggested that a 
decrease of the normal membrane phospholipid asymmetry 
in erythrocytes and lymphocytes led to increased MC540 
binding [11-14], as loss of asymmetry leads to a less tight 
packing of the outer leaflet of the membrane. 
Experiments reported by Allan et al. [15] did not sup- 
port this assumption, however. These authors prepared 
human erythrocyte ghosts that had maintained their normal 
phospholipid asymmetry but were permeable to MC540. It 
appeared that these asymmetric, open ghosts bound only 
twice as much MC540 as compared to intact erythrocytes. 
Apparently the inner leaflet, with its high concentration f 
phosphatidylethanolamine and phosphatidylserine, which 
are rich in unsaturated, loosely packed fatty acids, did not 
bind more MC540 than the more closely packed outer 
leaflet, contradicting earlier suggestions in the literature. 
When comparing experimental results reported by dif- 
ferent laboratories, a complicating factor is the use of 
different methods for measuring MC540 binding to the 
cells. In some cases bound MC540 was extracted from the 
cells with subsequent measurement of the dye concentra- 
tion in the extraction fluid. In other studies binding was 
assayed by measuring directly the fluorescence of 
MC540-1oaded cells. A direct comparison of results ob- 
tained by these two different approaches i hampered by 
the fact that the fluorescence yield of bound MC540 not 
only depends on the amount of dye actually bound to the 
cells, but also on other factors like membrane potential and 
orientation of the dye molecules with respect o the phos- 
pholipid molecules, e.g., parallel or perpendicular [16,17]. 
Therefore, a systematic study of the effects of perturba- 
tion of the erythrocyte membrane structure with respect o 
bilayer asymmetry, lipid packing, surface charge and some 
other parameters on the amount and mode of MC540 
binding was undertaken and the results compared with the 
binding to leukemia cells, in order to try to explain the 
difference between the low-affinity binding in erythrocytes 
and the high-affinity binding in leukemia cells. 
2. Materials and methods 
MC540 was purchased from Eastman Kodak, Rochester, 
NY. Stock solutions (1 mg/ml) were prepared in 50% 
ethanol. Chlorpromazine was obtained from Specia, Paris, 
A1PcS 4 from Eastman Kodak, Rochester, NY, DIDS from 
Pierce, Rockford, IL, TMA-DPH from Molecular Probes, 
Eugene, OR, Dextran 4 from Serva, Heidelberg, Germany 
and tissue culture products from Gibco-BRL, Breda, The 
Netherlands. All other chemicals were from Sigma, St. 
Louis, MO, USA or Baker, Deventer, The Netherlands. 
Heparinized human blood was centrifuged shortly after 
collection. The erythrocytes were washed three times in 
PBS and, unless otherwise specified, resuspended at 2% 
hematocrit n a medium containing (mM) KCI, 90; NaCI, 
45; Na2HPO4/NaH2PO4, 12.5, pH 7.4 and sucrose, 44 
(medium A). Open erythrocyte ghosts were prepared as 
described by Weed et al. [18]. BNML cells [19] were 
cultured in RPMI 1640, supplemented with 10% fetal calf 
serum and 4 mM glutamine. 
Binding of MC540 to erythrocytes and ghosts was 
assayed as described by Allan et al. with some modifica- 
tions [15]. Briefly, a 1 ml erythrocyte suspension was 
incubated in the dark with 17.5 /zM MC540 in the pres- 
ence of 0.15% BSA at 22 ° C. BSA was added to eliminate 
nonspecific binding of MC540 by competing for dye 
molecules [20]. After centrifugation i  an Eppendorf cen- 
trifuge (14000 rpm for 5 rain) the supernatant was re- 
moved. The pellet was resuspended in 1 ml medium A and 
a 100 /zl sample of this suspension was added to 2 ml of 
n-butanol and vortexed for 10 s. The amount of MC540 in 
the butanol solution was determined by measuring the 
fluorescence ( xcitation 540 nm, emission 580 rim) with an 
Aminco SPF-500 spectrofluorometer. In experiments in 
which the relative affinity of MC540 for the erythrocyte 
membrane under varying experimental conditions was esti- 
mated, the release of cell-bound MC540 during two wash- 
ing steps of the cells in 1 ml medium A containing 0.15% 
BSA and one washing step in 1 ml medium A was 
monitored. 
To measure the relative fluorescence quantum yield and 
emission maximum of cell-bound MC540, cells and 
medium were separated by centrifugation. The cells were 
resuspended in fresh medium A at a hematocrit of 0.02% 
and immediately assayed for fluorescence ( xcitation 540 
nm). A second sample was treated identically but cen- 
trifuged immediately after resuspending. The fluorescence 
of the supernatant, representing MC540 released from the 
cells, was subtracted from the fluorescence of the cell 
suspension, to obtain fluorescence data of cell-bound 
MC540. The so obtained spectrum of cell-bound MC540 
was not affected by addition of hemoglobin to the super- 
natant in a concentration comparable to a 0.02% erythro- 
cyte suspension. The relative fluorescence quantum yield 
is defined as the quantum yield of cell-bound MC540 
divided by the quantum yield of the dye at the same 
concentration i aqueous olution, both measured at the 
emission maximum [21]. 
In parallel experiments he relative fluorescence quan- 
tum yield of cell-bound MC540 was assayed by flow 
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Fig. 1. Binding of MC540 to human erythrocytes (O)  and open ghosts (O), in the presence of 0.15% BSA in the medium. Initial MC540 concentration in 
the medium: 17.5 /zM. Arrow: cells subjected to three washing steps with albumin-containing buffer. 
cytometry in a Becton-Dickinson FACS-IV fluorescence 
activated cell sorter (exc. 514 nm, em. > 525 nm). The 
results with these two methods were always in good 
agreement. 
Treatment of erythrocytes with tetrathionate or diamide 
was done as described by Haest et al. [22]. Briefly, an 
erythrocyte suspension (hematocrit 10%) was treated with 
20 mM tetrathionate or with 5 mM diamide for 40 min at 
37 ° C, pH 8.0, followed by a further incubation in fresh 
medium A. Lowering of the cytoplasmic ATP concentra- 
tion was performed as described by Middelkoop et al. [23]. 
Cytoplasmic ATP concentrations were measured with fire- 
fly lantern extract, using a BioOrbit 1251 Luminometer. 
Pre-incubation of erythrocytes with 5 /zM gramicidin was 
performed at 37°C for 30 min [24] and with 100 /zM 
chlorpromazine or 100 /.~M decanol at 22°C during 30 
min. Erythrocytes were incubated with 2 mM t-BuOOH as 
described by Classen et al. [25], with 10% PEG 6000 as 
described by Schwichtenhovel et al. [26] and with DIDS 
according to Lepke et al. [27]. Illumination of MC540- 
loaded cells with white light was done as described before 
[28]. Photodynamic treatment of erythrocytes with AIPcS 4 
(2.5 /zM) as sensitizer was performed as described previ- 
ously [29]. Enzymatic removal of sialic acid residues from 
the outer surface of the erythrocyte membrane was accom- 
plished as described by Goubran Botros et al. [30]. Electro- 
poration was carried out as described by Dressier et al. 
[31]. Briefly, an erythrocyte suspension (30% hematocrit) 
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Fig. 2. Fluorescence emission spectra (excitation 540 nm) of unbound MC540 in medium A ( - - )  erythrocyte-bound MC540 (- - 
bound to open ghosts ( - -  - -) .  The final MC540 concentration was 1 ~M in all cases. 
-) and MC540 
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in medium A containing 8.8% (w/v)  Dextran 4 instead of 
sucrose was filled in a discharge chamber at 0 ° C. The 
suspension was exposed to 80/xs field pulses at 8 kV/cm. 
To reseal the permeability barrier the suspension was 
incubated for 1 h at 37 ° C, before exposing the cells to 
MC540. 
The cholesterol content of erythrocyte membranes was 
lowered as described by Gottlieb [32]. Briefly, cell-free 
human plasma was incubated at 37 ° C. After 72 h erythro- 
cytes (10% hematocrit) and glucose (0.25%) were added 
and the incubation was continued for another 16 h. Ap- 
prox. 35% of the cholesterol was removed from the mem- 
branes by this procedure. Cholesterol was extracted as 
described by Rose and Oklander [33] and assayed as 
described by Omodeo Sal~ et al. [34]. Lipid peroxidation 
was essayed by measuring the generation of thiobarbituric 
acid reactive species as described by Miller et al. [35] and 
the formation of fatty acyl hydroperoxides a  described by 
Thomas and Girotti [36]. 
Fluorescence microscopy was performed with a Bio-Rad 
MRC 600 confocal aserscan microscope (exc. 488 nm, 
em. > 510 nm). 
All measurements were done at least eight times with 
an experimental error of < 8%. 
3. Results 
3.1. Characterization of binding of MC540 to intact ery- 
throcytes and ghosts 
The binding of MC540 in the presence of 0.15% BSA 
to intact erythrocytes and to open ghosts, as measured after 
extraction of bound dye with n-butanol, is depicted in Fig. 
1. The binding to intact erythrocytes levels off after about 
5 min at a binding of 2.7- 106 molecules/cell. The emis- 
sion maximum of erythrocyte-bound MC540 was at 572 
nm and the fluorescence yield was equal to the yield of 
unbound MC540 in medium A at the same concentration 
(Fig. 2). After washing the cells with albumin-containing 
buffer as described in the methods ection, dye binding 
decreased by 97% to 0.08.10 6 molecules/cell (Fig. 1). 
The same results were obtained at 0 ° C. Treatment of the 
cells with DIDS, which blocks the anion binding site of 
band 3, caused a slightly reduced MC540 binding, without 
affecting the other binding characteristics (Table 1). MC540 
binding to open ghosts amounted to 5.4.  106 
molecules/cell (Fig. 1). The fluorescence emission maxi- 
mum was red-shifted to 582 nm and the relative fluores- 
cence quantum yield was increased to 4.7 (Fig. 2). Wash- 
ing of the ghosts with albumin-containing buffer released 
about 85% of the initially bound MC540 (Fig. 1). 
3.2. Effect of treatments hat enhance transbilayer reorien- 
tation of lipids 
Gramicidin enhances the transbilayer eorientation 
(flip-flop) of lipids in the erythrocyte membrane, without 
affecting the normal phospholipid asymmetry between the 
inner and outer leaflet [24]. As shown in Table 1 treatment 
of erythrocytes with gramicidin had no effect on any of the 
MC540 binding characteristics. Treatment of the cells with 
t-BuOOH, also known to enhance the flip-flop rate about 
15-fold at a concentration of 2 mM [25] again failed to 
affect he binding characteristics (Table 1). 
Treatment of intact red blood cells with SH-oxidizing 
Table 1 
The effects of perturbation of the structure of the erythrocyte membrane on the characteristics of MC540 binding 
Pretreatment Binding, molecules/cell Em. max., Rel. fluoresc. Washed out, Binding after washing, 
(x  10- 6) nm quantum yield % molecules/cell ( x 10- 6) 
None 2.7 572 1.0 97 0.08 
Ghosts 5.4 582 4.7 85 0.80 
DIDS 2.5 572 1.1 98 0.05 
Gramicidin 2.7 572 0.99 96 0.10 
t-BuOOH 2.8 572 0.97 97 0.08 
Tetrathionate 2.7 572 0.93 96 0.10 
Tetrathionate + ATP depletion 2.4 585 6.5 88 0.29 
Diamide 2.8 572 1.1 97 0.08 
Diamide + ATP depletion 2.5 585 4.7 84 0.40 
Electroporation 3.1 582 4.4 84 0.26 
Cholesterol depletion 2.6 572 1.0 97 0.08 
mlPcS 4 + light, 20 min 3.5 585 7.8 87 0.44 
Light (MC540), 5 min 2.6 585 5.6 83 0.17 
Heat, 46 ° C, 2 h 2.8 572 1.0 97 0.08 
Heat, 48 ° C, 2 h 2.6 585 5.8 96 0.09 
Neuraminidase 3.4 580 2.7 98 0.09 
PEG, 10% 2.7 575 2.2 96 0.10 
Decanol 2.6 580 2.5 97 0.08 
Chlorpromazine 4.1 585 6.3 79 0.84 
Chlorpromazine, 0 ° C 3.6 585 6.2 92 0.28 
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Fig. 3. The effect of incubation after tetrathionate tr atment on cytosolic ATP concentration (O) and relative fluorescence quantum yield of cell-bound 
MC540 ( • ). 
reagents like diamide or tetrathionate did not lead to a 
change of MC540 binding characteristics, when measured 
immediately after treatment. During further incubation of 
the cells in reagent-free buffer A, however, a gradual shift 
of the emission maximum to 585 nm and a pronounced 
increase of the relative fluorescence quantum yield could 
be observed, without increased MC540 binding to the cells 
(Fig. 3, Table 1). These changes tarted when the ATP 
content of the cytosol had decreased to about 6% of the 
original value. In further experiments it could be demon- 
strated that the decreased ATP concentration was crucial 
for the observed changes of the fluorescence character- 
istics of bound MC540. If the erythrocytes were ATP-de- 
pleted before treatment with tetrathionate, the increased 
fluorescence quantum yield and the red-shift of the emis- 
sion maximum occurred immediate ly  after treatment (not 
shown). These results indicate that loss of phospholipid 
asymmetry is involved in the changed fluorescence harac- 
teristics of bound MC540 [23]. In line with these findings a 
decrease of phospholipid asymmetry produced by electro- 
poration of cells followed by resealing [31] also resulted in 
a red-shift of the emission maximum and an increase of 
the fluorescence quantum yield (Table 1). The amount of 
MC540 that remained bound to the cells after the standard 
washing procedure was substantially higher (12-16%) than 
with control cells (3.1%, Table 1). 
3.3. Effect of cholesterol depletion 
Cholesterol  deplet ion of  the membrane may lead to a 
less t ight packing of the phosphol ip ids  in the outer leaflet 
of  the membrane [8]. However ,  extract ion of  about 35% of 
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Fig. 4. The effect of photodynamic treatment with AIPcS 4 as sensitizer on emission maximum (O) and relative fluorescence quantum yield ( . )  of 
cell-bound MC540. 
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Table 2 
Characteristics of MC540 binding to normal, intact erythrocytes, A1PcS4-photodynamically treated erythrocytes and to BNML cells 
433 
Normal  A1PcS4-photodynamically BNML 
erythrocytes treated erythrocytes cells 
Binding, molecules/cell (X 10-6) 
Cholesterol content, fmol/cell 
Surface area,/xm2/cell 
Binding, molecules/p.m 2 ( X 10- 3) 
Em. max, nm 
Rel. fluoresc, quantum yield 
Washing out, % 
Binding after washing, molecules/cell ( X10 -6 ) 
Binding after washing, molecules//xm 2 ( × 10- 3) 
2.7 3.5 100 
0.34 0.34 3.6 
135 135 1286 
20 26 78 
572 585 580 
1.0 7.8 5.6 
97 87 84 
0.08 0.44 16 
0.59 3.38 12 
the cholesterol from the membrane, changing the choles- 
terol/phospholipid ratio (w/w)  from 0.40 to 0.23, had no 
effect on the MC540 binding characteristics (Table 1). 
3.4. Effect of  photodynamic treatment 
Treatment of red blood cells with the sensitizer mlPcS 4 
in the dark did not affect MC540 binding. If these cells 
were illuminated during 20 min, however, subsequent in- 
cubation with MC540 led to a 30% increase of MC540 
binding, a shift of the emission maximum to 585 nm, an 
eightfold increase of the relative fluorescence quantum 
yield and a decreased extraction of the dye during subse- 
quent washing (Fig. 4, Table 1). As MC540 itself is a 
photosensitizer, similar experiments were conducted with 
cells, incubated with MC540 only. During illumination of 
the cells MC540 binding did not increase, but the emission 
maximum shifted to 585 nm, again with a concomitant 
increase of the relative fluorescence quantum yield and a 
decreased extraction of dye by washing (Table 1). These 
photodynamic treatments of the erythrocytes did not cause 
measurable lipid peroxidation as judged from the lack of 
generation of thiobarbituric acid reactive products and 
fatty acyl hydroperoxides (not shown). 
3.5. Effect of various other membrane structure-perturbing 
treatments 
The effects of various other treatments leading to per- 
turbation of the membrane structure are summarized in 
Table 1. Heat treatment at 48 ° C (but not at 46 ° C) for 2 h 
caused a red-shift of the fluorescence mission peak and 
an increased fluorescence quantum yield. This effect was 
observed when the red cells were heat-treated and subse- 
quently cooled to room temperature before MC540 was 
added. Pretreatment of the cells with neuraminidase or 
Fig. 5. Fluorescence micrograph ofBNML cells incubated with 17.5/xM MC540 in the presence of0.15% BSA. Original magnification: 800 ×. Bar = 10 
p,m, 
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addition of PEG 6000 or decanol to the incubation medium 
had a similar effect, although less pronounced. Finally the 
effect of chlorpromazine, known to intercalate between the 
phospholipid molecules in the membrane, was investi- 
gated. As shown in Table 1 MC540 binding increased by 
50%, the emission maximum of cell-bound ye shifted to 
585 nm and the relative fluorescence quantum yield in- 
creased 6-fold. Because chlorpromazine induces endocyto- 
sis [37] MC540 binding to chlorpromazine-treated c lls 
was also measured at 0 ° C. Binding was slightly lower at 
0°C whereas the amount of MC540 that remained bound 
to the cells after the standard washing procedure was 
substantially ower (8%) at 0 ° C than at room temperature 
(21%). 
3.6. MC540 binding to BNML cells 
Table 2 summarizes the binding characteristics of 
MC540 to BNML cells, as compared to human erythro- 
cytes. Also in this case the same results were obtained at 
0 ° C. Fluorescence microscopy showed that the binding 
was restricted to the plasma membrane (Fig. 5). The 
binding in molecules/cell was recalculated to binding per 
surface area. Human erythrocytes have a mean surface area 
of 135 /xm: [38] and a cholesterol content of 0.34 
fmol/cell. Lange et al. showed that in many cells the ratio 
cholesterol content/surface area is the same [39]. The 
cholesterol content of BNML cells was 3.6 fmol/cell. The 
surface area calculated in this way amounted to 1286/zm 2. 
Comparable results were obtained when measuring the 
surface area of BNML cells with the fluorescent dye 
TMA-DPH as described by Bronner et al. [40]. 
The emission maximum of cell-bound MC540 was 
red-shifted compared to MC540 bound to red blood cells 
(580 nm versus 572 nm) and the relative fluorescence 
quantum yield was 5.6-times higher. The percentage of 
MC540 that remained bound to the cells after washing 
with albumin-containing buffer was much higher in BNML 
cells, compared to erythrocytes (Table 2). 
4. Discussion 
Under the experimental conditions used in this study, 
MC540 binding to intact human erythrocytes amounted to 
2.7.106 molecules/cell. It is highly unlikely that this 
binding is caused by endocytosis, as changing the tempera- 
ture from 22 ° C to 0 ° C had no effect. Binding to the anion 
binding site of band 3 molecule cotild also be excluded. 
After treatment of the cells with DIDS, MC540 binding 
was only slightly reduced (Table 1). 
The fluorescence emission maximum of MC540 bound 
to untreated erythrocytes was at 572 nm. The fluorescence 
emission maximum of MC540 depends on the dielectric 
constant of the environment, changing from about 572 nm 
in buffer, to about 585 nm in solvents with a low dielectric 
constant [41]. This red-shift is attended with an 8- to 
12-fold increase of the relative fluorescence quantum yield 
[21]. In model experiments it has been shown that MC540 
binding to phospholipid layers can occur in at least two 
ways [10,16,17]. The first possibility is that the dye is 
largely in contact with the water phase with its long axis 
perpendicular to the long axis of the phospholipid 
molecules. In this case the fluorescence mission maxi- 
mum is at 572 nm [10]. Secondly, the dye is predominantly 
in contact with the hydrocarbon matrix with its long axis 
parallel to the long axis of the phospholipid molecules. In 
this configuration MC540 exhibits a fluorescence emission 
maximum at 585 nm [10]. Based on these observations, it 
seems highly likely that in untreated erythrocytes most 
bound MC540 molecules are in close contact with the 
surrounding water with their long axis perpendicular to the 
long axis of the phospholipids. 
Several studies emphasize the importance of lipid pack- 
ing in the outer leaflet of the membrane bilayer for MC540 
binding [11-14]. Normally the phospholipids in the ery- 
throcyte membrane are distributed asymmetrically with 
most of the phosphatidylcholine and sphingomyelin local- 
ized in the outer leaflet and most of the phosphatidylserine 
and -ethanolamine in the inner leaflet [42]. This asymmetry 
is maintained by an ATP-dependent aminophospholipid 
translocase ('flippase') [43,44], together with an interac- 
tion of spectrin with the anionic phospholipids in the inner 
leaflet of the bilayer [45]. Because the fatty acid chains of 
phosphatidylcholine and sphingomyelin are much more 
saturated than the acyl chains of phosphatidylserine and 
-ethanolamine, the outer leaflet is much more tightly packed 
than the inner leaflet. Thus, if lipid packing is indeed 
important in MC540 binding, it should be expected that 
leaky ghosts would bind appreciably more than twice the 
amount of MC540, compared to intact cells. However, as 
also shown by Allan et al. [15], binding to open ghosts is 
only twice the amount bound to intact cells (Fig. 1, Table 
1). It should also be expected that erythrocytes that had 
lost their normal phospholipid asymmetry, causing a less 
tight lipid packing in the outer leaflet, bind more MC540 
than untreated cells. However treatment of cells with SH- 
oxidizing agents combined with inhibition of the flippase 
by ATP-depletion [23], or electroporation f cells [31] did 
not enhance the amount of bound MC540. But in all these 
cases the mode of MC540 binding changed. The emission 
maximum of bound MC540 was red-shifted to 582-585 
nm, compared to 572 nm for MC540 bound to untreated 
erythrocytes. Also the relative fluorescence quantum yield 
was about 5-times higher and an appreciably lower per- 
centage of dye could be washed out with albumin-contain- 
ing buffer (Fig. 1, Table 1). These observations suggest 
that in bilayer leaflets with less tight packing of the acyl 
chains many of the MC540 molecules have an orientation 
in which the dye is in close contact with the hydrocarbon 
matrix with its main axis parallel to the phospholipid 
molecules in the bilayer. The fluorescence characteristics 
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of MC540 bound to BNML cells indicate that the dye is 
located in the plasma membrane of these cells in a compa- 
rable way. 
Flip accelerations that do not result in a significant 
phospholipid asymmetry, induced by treatment of cells 
with the SH-oxidizing agents diamide and tetrathionate 
[46], by heat treatment at 46°C [47] or by insertion of 
gramicidin into the membrane [24], did not enhance bind- 
ing or produce changes of the binding characteristics (Ta- 
ble 1). 
Changes of MC540 binding characteristics ould also 
be observed with some other treatments, causing perturba- 
tion of the membrane structure, not related to a change in 
phospholipid asymmetry. Exposure of the cells to PEG 
6000 or decanol did not change the amount of bound 
molecules but had a slight effect on the emission maxi- 
mum and on the relative fluorescence quantum yield (Ta- 
ble 1). The effects may be attributable to the lowering of 
the apparent surface polarity of the cells by these com- 
pounds [26]. 
Heat treatment at temperatures of 48°C or higher re- 
suited in relatively strong changes in the mode of binding, 
again without affecting the total amount of membrane- 
bound MC540. These changes can not be ascribed to a 
temperature-induced hange of the phospholipid core to a 
more fluid phase, as the changed binding characteristics 
were observed after cooling of the cell suspension. Instead, 
the red-shift of the emission peak and the increased fluo- 
rescence quantum yield coincided with the development of
persistent morphological changes of the cells (poikilocyto- 
sis). 
Chlorpromazine perturbs the lipid structure of the ery- 
throcyte membrane, reflected by a fluidizing effect [48] 
and a changed interaction between membrane lipids and 
intrinsic membrane proteins [49]. Treatment with this com- 
pound resulted in an enhanced amount of bound MC540, a 
higher emission maximum, an about 6-times higher rela- 
tive fluorescence quantum yield and a decreased possibil- 
ity to wash out the MC540 molecules. The enhanced 
amount of bound MC540 after insertion of the cationic 
anaesthetic chlorpromazine into the membrane may be 
partly caused by chlorpromazine-induced en ocytosis, as 
indicated by the effect of temperature (Table 1). Also 
electrostatic interaction of MC540 with chlorpromazine is 
probably involved. The change in the other binding param- 
eters again indicates a different localization and/or orien- 
tation of the dye. 
The influence of an altered surface charge was studied 
by treatment with neuraminidase, which removes the nega- 
tively charged sialic acid residues. This treatment resulted 
in a slightly increased amount of MC540 bound to the 
cells. In line with this observation, insertion of the anionic 
lysophosphatidylserine (2.4.107 molecules/cell), into the 
outer leaflet decreased the binding of MC540 by 24% [50]. 
Removal of sialic acid residues also resulted in a higher 
emission maximum, and a higher relative fluorescence 
quantum yield and thus to a change in the environment of
the MC540 molecules. 
Photodynamic treatment with AIPcS 4 and MC540 as 
sensitizers caused a change in the amount and in the mode 
of MC540 binding, which is much more pronounced in the 
case of AIPcS 4. It has been shown that treatment with 
AIPcS 4 and light causes a perturbation of the membrane 
structure, reflected, e.g., by enhanced transbilayer mobility 
of membrane lipid probes [29]. However, as discussed 
above, the change of MC540 binding characteristics an 
not be explained by increased flip-flop. Apparently photo- 
dynamic treatment induces other, as yet unknown struc- 
tural changes in the erythrocyte membrane, leading to 
increased MC540 binding and a change of its binding 
characteristics. 
In conclusion, some of the erythrocyte membrane per- 
turbations evoke a change in the MC540 binding character- 
istics, that is qualitatively comparable to the high-affinity 
binding of the dye to BNML cells. However, calculated 
per surface area BNML cells still bind 3-times more 
MC540 molecules, compared to photodynamically treated 
red blood cells (Table 2). 
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